Conversely, the immunosuppressive properties of GCs may attenuate intrahepatic low-grade chronic inflammation, largely mediated by interleukin-6 (IL-6), which could partly explain the relatively low prevalence of MASLD reported in overt Cushing syndrome in some studies [162]. The gene discussed is IL6; the disease is Cushing syndrome.